(NASDAQ: MDCX) is a clinical-stage biotech company working on disruptive approaches to cancer and urologic disease. The ...
Diabetes mellitus (DM) is a possible risk factor for post-COVID-19 pulmonary fibrosis (PCPF), according to meta-analysis study findings published in BMC Pulmonary Medicine.
A research group from the National Cancer Research Center (CNIO) has found that an alteration in the POT1 gene prevents lung tissue from regenerating, which over time makes breathing difficult. The ...
News-Medical.Net on MSN
POT1 gene mutation linked to pulmonary fibrosis through telomere dysfunction
Idiopathic pulmonary fibrosis is a potentially fatal disease currently without treatment, in which lung tissue develops scarring and becomes stiff, making breathing increasingly difficult over time.
News-Medical.Net on MSN
Neurons play a key role in reducing lung inflammation in pulmonary fibrosis
Researchers at the University of Calgary studying a lethal lung disease called pulmonary fibrosis have found neurons, which were known to help detect pain, are also critical for reducing harmful lung ...
CHICAGO, Sept. 2, 2025 /PRNewswire/ -- September is Pulmonary Fibrosis Awareness Month, and the American Lung Association today announced a new educational program to help people living with pulmonary ...
Polyethylene terephthalate microplastics are the most common microplastics encountered in daily life, and there are several reasons why they may play a role in lung diseases like idiopathic pulmonary ...
CHICAGO (WLS) -- There was a big celebration to welcome a long-time Chicago Cubs superfan to Sunday's game. Ronnie "Woo Woo" Wickers was mobbed by people and a some were holding signs. He had yet to ...
A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly ...
In her columns debut, Debbie Klein shares the story of her late husband Steve's idiopathic pulmonary fibrosis diagnosis.
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., September 02, 2025--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that its TETON-2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results